Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location

被引:202
作者
Karremann, Michael [1 ]
Gielen, Gerrit H. [2 ]
Hoffmann, Marion [3 ]
Wiese, Maria [3 ]
Colditz, Niclas [3 ]
Warmuth-Metz, Monika [4 ]
Bison, Brigitte [4 ]
Claviez, Alexander [5 ]
van Vuurden, Dannis G. [6 ]
von Bueren, Andre O. [3 ,7 ]
Gessi, Marco [2 ]
Kuehnle, Ingrid [3 ]
Hans, Volkmar H. [8 ,9 ]
Benesch, Martin [10 ]
Sturm, Dominik [11 ]
Kortmann, Rolf-Dieter [12 ]
Waha, Andreas [2 ]
Pietsch, Torsten [2 ]
Kramm, Christof M. [3 ]
机构
[1] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Pediat & Adolescent Med, Mannheim, Germany
[2] Univ Hosp Bonn, Dept Neuropathol, Bonn, Germany
[3] Univ Med Ctr Goettingen, Dept Child & Adolescent Hlth, Div Pediat Hematol & Oncol, Gottingen, Germany
[4] Univ Hosp Wuerzburg, Dept Neuroradiol, Wurzburg, Germany
[5] Schleswig Holstein Med Univ Kiel, Dept Pediat, Kiel, Germany
[6] Vrije Univ Amsterdam, Med Ctr, Div Oncol Hematol, Dept Pediat, Amsterdam, Netherlands
[7] Univ Hosp Geneva, Div Pediat Hematol & Oncol, Dept Pediat & Adolescent Med, Geneva, Switzerland
[8] Univ Med Greifswald, Dept Pathol, Greifswald, Germany
[9] Evangel Krankenhaus Bielefeld, Inst Neuropathol, Bielefeld, Germany
[10] Med Univ Graz, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Graz, Austria
[11] German Canc Res Ctr Heidelberg, Div Pediat Neurooncol, Heidelberg, Germany
[12] Univ Leipzig, Dept Radiotherapy & Radiat Oncol, Med Ctr, Leipzig, Germany
关键词
children; diffuse midline glioma; high-grade glioma; histone H3; K27M mutation; GROSS TOTAL RESECTION; MALIGNANT GLIOMAS; GENETIC ALTERATIONS; PEDIATRIC-PATIENTS; HISTONE H3.3; H3F3A; GLIOBLASTOMA; SUBGROUPS; DEFINE; FREQUENCY;
D O I
10.1093/neuonc/nox149
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The novel entity of "diffuse midline glioma, H3 K27M-mutant" has been defined in the 2016 revision of the World Health Organization (WHO) classification of tumors of the central nervous system (CNS). Tumors of this entity arise in CNS midline structures of predominantly pediatric patients and are associated with an overall dismal prognosis. They are defined by K27M mutations in H3F3A or HIST1H3B/C, encoding for histone 3 variants H3.3 and H3.1, respectively, which are considered hallmark events driving gliomagenesis. Here, we characterized 85 centrally reviewed diffuse gliomas on midline locations enrolled in the nationwide pediatric German HIT-HGG registry regarding tumor site, histone 3 mutational status, WHO grade, age, sex, and extent of tumor resection. We found 56 H3.3 K27M-mutant tumors (66%), 6 H3.1 K27M-mutant tumors (7%), and 23 H3-wildtype tumors (27%). H3 K27M-mutant gliomas shared an aggressive clinical course independent of their anatomic location. Multivariate regression analysis confirmed the significant impact of the H3 K27M mutation as the only independent parameter predictive of overall survival (P = 0.009). In H3 K27M-mutant tumors, neither anatomic midline location nor histopathological grading nor extent of tumor resection had an influence on survival. These results substantiate the clinical significance of considering diffuse midline glioma, H3 K27M-mutant, as a distinct entity corresponding to WHO grade IV, carrying a universally fatal prognosis.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 41 条
[21]  
Kramm CM, 2006, ANTICANCER RES, V26, P3773
[22]   Thalamic high-grade gliomas in children: a distinct clinical subset? [J].
Kramm, Christof M. ;
Butenhoff, Sandra ;
Rausche, Ulrike ;
Warmuth-Metz, Monika ;
Kortmann, Rolf-Dieter ;
Pietsch, Torsten ;
Gnekow, Astrid ;
Jorch, Norbert ;
Janssen, Gisela ;
Berthold, Frank ;
Wolff, Johannes E. .
NEURO-ONCOLOGY, 2011, 13 (06) :680-689
[23]   Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma [J].
Lewis, Peter W. ;
Mueller, Manuel M. ;
Koletsky, Matthew S. ;
Cordero, Francisco ;
Lin, Shu ;
Banaszynski, Laura A. ;
Garcia, Benjamin A. ;
Muir, Tom W. ;
Becher, Oren J. ;
Allis, C. David .
SCIENCE, 2013, 340 (6134) :857-861
[24]  
Louis DN., 2007, WHO CLASSIFICATION T
[25]   BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma [J].
Mistry, Matthew ;
Zhukova, Nataliya ;
Merico, Daniele ;
Rakopoulos, Patricia ;
Krishnatry, Rahul ;
Shago, Mary ;
Stavropoulos, James ;
Alon, Noa ;
Pole, Jason D. ;
Ray, Peter N. ;
Navickiene, Vilma ;
Mangerel, Joshua ;
Remke, Marc ;
Buczkowicz, Pawel ;
Ramaswamy, Vijay ;
Stucklin, Ana Guerreiro ;
Li, Martin ;
Young, Edwin J. ;
Zhang, Cindy ;
Castelo-Branco, Pedro ;
Bakry, Doua ;
Laughlin, Suzanne ;
Shlien, Adam ;
Chan, Jennifer ;
Ligon, Keith L. ;
Rutka, James T. ;
Dirks, Peter B. ;
Taylor, Michael D. ;
Greenberg, Mark ;
Malkin, David ;
Huang, Annie ;
Bouffet, Eric ;
Hawkins, Cynthia E. ;
Tabori, Uri .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :1015-+
[26]   Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours [J].
Nguyen, A. T. ;
Colin, C. ;
Nanni-Metellus, I. ;
Padovani, L. ;
Maurage, C-A ;
Varlet, P. ;
Miquel, C. ;
Uro-Coste, E. ;
Godfraind, C. ;
Lechapt-Zalcman, E. ;
Labrousse, F. ;
Gauchotte, G. ;
Silva, K. ;
Jouvet, A. ;
Figarella-Branger, D. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (03) :403-408
[27]   Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma [J].
Pages, Melanie ;
Beccaria, Kevin ;
Boddaert, Nathalie ;
Saffroy, Raphael ;
Besnard, Aurore ;
Castel, David ;
Fina, Frederic ;
Barets, Doriane ;
Barret, Emilie ;
Lacroix, Ludovic ;
Bielle, Franck ;
Andreiuolo, Felipe ;
Tauziede-Espariat, Arnault ;
Figarella-Branger, Dominique ;
Puget, Stephanie ;
Grill, Jacques ;
Chretien, Fabrice ;
Varlet, Pascale .
BRAIN PATHOLOGY, 2018, 28 (01) :103-111
[28]  
Pollack IF, 2001, CANCER RES, V61, P7404
[29]   Treatment of early childhood medulloblastoma by postoperative chemotherapy alone [J].
Rutkowski, S ;
Bode, U ;
Deinlein, F ;
Ottensmeier, H ;
Warmuth-Metz, M ;
Soerensen, N ;
Graf, N ;
Emser, A ;
Pietsch, T ;
Wolff, JEA ;
Kortmann, RD ;
Kuehl, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :978-986
[30]   Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma [J].
Ryall, Scott ;
Krishnatry, Rahul ;
Arnoldo, Anthony ;
Buczkowicz, Pawel ;
Mistry, Matthew ;
Siddaway, Robert ;
Ling, Cino ;
Pajovic, Sanja ;
Yu, Man ;
Rubin, Joshua B. ;
Hukin, Juliette ;
Steinbok, Paul ;
Bartels, Ute ;
Bouffet, Eric ;
Tabori, Uri ;
Hawkins, Cynthia .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 :93